We provided an overview of the role of CNR1 gene in EDs and obesity, in order to further stimulate the challenging idea that the modulation of CNR1 gene transcriptional regulation might represent a promising approach to prevent or to treat these pathologies, in addition to existing pharmacological interventions on CB1R [103]. The gene discussed is CNR1; the disease is obesity due to melanocortin 4 receptor deficiency.